The Ras-Raf-MEK-ERK pathway in the treatment of cancer. [electronic resource]
Producer: 20030423Description: 511-8 p. digitalISSN:- 0378-584X
- Animals
- Antineoplastic Agents -- adverse effects
- Cell Division -- drug effects
- Cell Survival -- drug effects
- Clinical Trials, Phase I as Topic
- Humans
- MAP Kinase Kinase Kinase 1
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins c-raf -- antagonists & inhibitors
- Proto-Oncogene Proteins p21(ras) -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.